Sign in

You're signed outSign in or to get full access.

Faye Kurren

Director at FIRST HAWAIIANFIRST HAWAIIAN
Board

About Faye W. Kurren

Faye W. Kurren (age 74) is an independent director of First Hawaiian, Inc. (FHB) since 2018, and serves on the Audit and Compensation Committees; she is designated an “audit committee financial expert.” She is the retired President & CEO of Hawaii Dental Service (2003–2014) and previously served as President of Tesoro Hawaii, LLC (1998–2003); her education includes a J.D. from the University of Hawaii, an M.A. in Sociology from the University of Chicago, and a B.A. from Stanford University. She also currently serves on First Hawaiian Bank’s Senior Trust Committee.

Past Roles

OrganizationRoleTenureNotes/Impact
Hawaii Dental ServicePresident & CEO2003–2014Led a major local healthcare insurer; deep management and governance experience
Tesoro Hawaii, LLCPresident1998–2003Operating leadership in energy; public-company subsidiary experience
First Hawaiian BankSenior Trust Committee memberCurrentOversight role within the Bank’s trust governance

External Roles

OrganizationTypeRoleStatus
First Insurance Company of HawaiiInsuranceDirectorCurrent
Hawaii State Commission on the Status of WomenGovernmentPast ChairpersonHistorical role
University of Hawaii FoundationNon-profitPast ChairpersonHistorical role
American Red Cross – Hawaii ChapterNon-profitPast ChairpersonHistorical role

Board Governance

  • Committee assignments: Audit Committee member; Compensation Committee member; Senior Trust Committee at the Bank .
  • Independence: Board determined Kurren is independent under NASDAQ rules; no material relationships affecting independence disclosed .
  • Attendance and engagement: The Board met 7 times in 2024; each director attended more than 75% of Board and applicable committee meetings (Audit Committee met 5x; Compensation 10x; Corporate Governance 4x; Risk 4x) .
  • Tenure: Director since 2018; directors elected annually by majority vote standard; lead independent director succession addressed due to age policy .

Fixed Compensation

Component2024 Amount ($)Notes
Fees Earned or Paid in Cash90,000Director cash retainer and committee fees aggregate
Stock Awards (RSUs) – grant date fair value69,984RSUs awarded under the Non-Employee Director Plan
All Other Compensation8,118Includes $6,000 for Bank committee meeting fees and $2,118 noncash gift
Total168,102Sum of components above

Director compensation program structure (for context):

Role/ServiceAnnual Cash ($)Equity Grant Value ($)Committee Supplemental Cash ($)
Board member (non-employee)65,00070,000
Audit/Risk Chair24,000
Audit/Risk Member15,000
Compensation Chair20,000
Compensation Member10,000
Corp Gov Chair17,500
Corp Gov Member8,000
Lead Independent Director35,000
Additional attendance fee (ad hoc/Bank committees)1,500 per meeting

Performance Compensation

Award TypeUnits/SharesGrant Date Fair Value ($)Vesting TermsPerformance Metrics
Restricted Stock Units (RSUs)3,15169,984Vest and settle on the earlier of one year after grant or next annual meeting; vest upon change in control; service-based None (time-based only)

Notes:

  • Director RSUs under the Non-Employee Director Plan are service-vested; no TSR/financial performance conditions apply .
  • Equity awards are settled in shares upon vesting; change-in-control accelerates vesting per plan terms .

Other Directorships & Interlocks

ItemDetail
Current public company boards (count)1 (as disclosed in nominee summary)
Named external board roleFirst Insurance Company of Hawaii – Director
Potential interlocks/conflictsNone disclosed requiring Item 404 related-party disclosure; ordinary course banking relationships overseen by policy and independence review

Expertise & Qualifications

  • Audit committee financial expert designation; brings financial oversight capability to Audit Committee .
  • Senior operating experience as President/CEO in healthcare insurance and energy, contributing to risk, governance, and management oversight .
  • Legal training (J.D.) and governance leadership across non-profit and public-sector organizations .

Equity Ownership

MeasureValueNotes
Shares beneficially owned25,418As of Feb 27, 2025
Ownership % of class<1%Less than 1% of 126,195,936 shares outstanding
Unvested director RSUs outstanding3,151Scheduled to vest on earlier of one year after grant or next annual meeting (service-based)
Director stock ownership guideline5x annual cash retainerCompliance period: later of five years from joining Board or Oct 20, 2026
Compliance statusIn compliance or within windowAll non-employee directors meet or are within window; pledging prohibited under guidelines

Governance Assessment

  • Board effectiveness: Dual committee service (Audit and Compensation) plus audit expert status indicates active oversight in financial reporting and pay governance; attendance thresholds met Board/committee-wide in 2024 .
  • Independence and conflicts: Board affirmed independence; related-party loan relationships disclosed for other directors and certain entities were ordinary course with market terms; no Item 404 related-party transactions disclosed for Kurren .
  • Director pay and alignment: Balanced cash/equity mix with service-vested RSUs; ownership guidelines (5x retainer) and anti-pledging policy support alignment; clawback policies across incentive compensation reinforce accountability .
  • Compensation committee governance: Use of independent consultants (Pay Governance through Sept 2024; Pearl Meyer thereafter) and robust oversight practices; strong shareholder support (>98% say-on-pay approval in 2024) reflects broader confidence in pay governance .

RED FLAGS: None disclosed regarding related-party transactions, hedging/pledging, or low attendance for Kurren; director RSUs are time-based without performance metrics, typical for non-employee directors .

Insider Filings and Trades

ItemStatus
Section 16(a) compliance (2024)Company believes officers and directors, including Kurren, complied with all filing requirements

Related Party Transactions Policy (Overview)

  • Transactions >$120,000 reviewed/approved by Audit Committee; ordinary-course loans to directors/family/related entities permitted on market terms and without unfavorable features; Audit Committee members conflicted on a transaction recuse from review .